Skip Ribbon Commands
Skip to main content
Forward Look

Guiding the Way

American Cancer Society releases prostate cancer survivorship guidelines. By Stephen Ornes

New treatment guidelines developed by the American Cancer Society and published in the July/August 2014 issue of CA: A Cancer Journal for Clinicians have the potential to help millions of men navigate prostate cancer survivorship.


More than 2.5 million men in the U.S.—40 percent of all male cancer survivors—have been treated for prostate cancer. When their cancer care ends, many of these men are likely to stop seeing an oncologist or urologist and resume seeing an internist or a general practitioner. However, these doctors may not be familiar with guiding prostate cancer patients through survivorship or addressing long-term side effects that may develop from the cancer or its treatment. The new guidelines help bridge this gap.
 
Risks from Radiation for Prostate Cancer
A study found that men treated for prostate cancer with external beam radiation are at greater risk for developing bladder and rectal cancer. 
“I encourage survivors to take these guidelines to their primary care physicians” and review the information with them, says Durado Brooks, an internist who directs Prostate and Colorectal Cancers for the American Cancer Society (ACS). Patients should be sure their primary care doctor received a treatment summary and long-term treatment plan from their urologist or oncologist, he says, and the primary care doctor should contact the specialist if any problems arise.
 
The guidelines include:
• Prostate-specific antigen (PSA) testing every six to 12 months for the first five years after treatment, then annually. Elevated PSA levels should be reported to the patient’s oncologist.
• Physical and psychosocial assessment, including screening for secondary cancers if indicated.
• Annual blood counts for men who received androgen-deprivation therapy, to watch for anemia.
• Discussions about sexual function and the use of validated tools for the assessment of erectile function.
 
“The transition from active treatment is a source of joy, relief and gratitude, but also anxiety and fear for many cancer survivors,” says Shelley Fuld Nasso, the chief executive officer of the National Coalition for Cancer Survivorship. Guidelines like those published by the ACS, she says, can help both patients and their doctors during this transition.

09/29/2014
SUBSCRIBE TO OUR E-NEWSLETTER

Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!